ArticleFrontiers in endocrinology2025
A machine learning model for predicting bone and/or lung metastasis in differentiated thyroid carcinoma: enhancing precision in risk stratification.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The value of machine learning models in predicting lung metastasis in papillary thyroid carcinoma.Frontiers in endocrinology · 2026Article
- An interpretable machine learning-based approach: development, validation, and clinical utility for distant metastasis prediction in PTC.Frontiers in endocrinology · 2026Article
- Nomogram for survival prediction in metastatic differentiated thyroid cancer and survival comparison between systemic chemotherapy and local radiotherapy in high-risk patients.World journal of surgical oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Differentiated thyroid cancer (DTC) incidence is rapidly rising worldwide. While most cases have a favorable prognosis, a subset of patients develop aggressive disease with distant metastases, particularly to the bone and lung, which significantly worsens outcomes. Current prediction models are limited in accuracy, often relying on basic clinical factors. This study aims to develop a machine learning model to improve prediction of bone and lung metastasis in DTC, enhancing risk stratification and early intervention. Methods: Using the SEER database, we developed several machine learning models-including XGBoost, Random Forest, Gradient Boosting Machine, Logistic Regression, Naive Bayes, and Classification and Regression Trees (CART)-to predict bone and lung metastasis risk in DTC patients. LASSO regression was applied to select key predictive variables, and SMOTE was used to address data imbalance. The model's generalizability was evaluated using an external validation cohort from China. Results: The XGBoost model demonstrated the highest performance, achieving an AUC of 0.988. Key predictive variables identified and included in the model were tumor size, radiation therapy, surgical interventions, histologic types, T and N stages, laterality, race, and household income. SHAP analysis confirmed the importance of these variables, with tumor size, radiation, and surgery emerging as primary predictors. In the external validation cohort, the model achieved an AUC of 0.866, indicating reliable predictive capability across clinical settings. Conclusion: This model accurately predicts bone and lung metastasis risk in DTC, offering valuable clinical utility for risk stratification and supporting early intervention strategies to improve outcomes in high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.